For growing biotech firms, obtaining capital can be a major hurdle. Hiring a dedicated Chief Financial Officer is typically excessively expensive, especially when profits are constrained. A fractional CFO offers a https://mathedsji785899.activoblog.com/51905751/fractional-cfo-a-biotech-funding-lifeline